A Phase 2 Study of Neoadjuvant Chemotherapy Plus Durvalumab in Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Cancer(2023)
Key words
durvalumab,head and neck cancer,neoadjuvant chemo-immunotherapy,oral cavity,oropharynx
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined